| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 195,163 | 183,917 | 199,160 | 225,690 | | Cost of Revenue | 59,631 | 112,053 | 123,412 | 98,958 | | | Gross Profit | 135,532 | 71,864 | 75,748 | 126,732 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 25,240 | 25,285 | 24,918 | 48,074 | | Non Recurring | 145,655 | 4,878 | 1,196 | 51,764 | | Others | 57,869 | 58,218 | 57,073 | 58,755 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (94,831) | (16,517) | (7,439) | (31,861) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (1,862) | 1,105 | 11,828 | 51,085 | | Earnings Before Interest And Taxes | (96,693) | (15,412) | 4,389 | 19,224 | | Interest Expense | 22,784 | 15,046 | 12,502 | 12,661 | | Income Before Tax | (119,477) | (30,458) | (8,113) | 6,563 | | Income Tax Expense | (50,405) | (14,620) | (4,562) | (1,918) | | Minority Interest |
-
| 3,658 | (3,658) | (8,184) | | | | Net Income From Continuing Ops | (89,584) | (12,180) | (7,209) | 297 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (89,903) | (12,180) | (7,209) | 297 | | Preferred Stock And Other Adjustments | 10,003 | (10,003) |
-
|
-
| | | Net Income Applicable To Common Shares | ($79,900) | ($22,183) | ($7,209) | $297 |
|
0.51% Nasdaq 
Income Statement
